Jim Datin

Directeur Général chez BioAgilytix Europe GmbH

Profil

Mr. Jim A. Datin is an Operating Partner at GHO Capital Partners LLP, a Chief Executive Officer & Director at BALX Holdings LLC and a Co-Managing Director at BioAgilytix Europe GmbH.
He is on the Board of Directors at The North Carolina Biotechnology Center, BALX Holdings LLC, Hepatitis B Foundation and Life Sciences Pennsylvania.
Mr. Datin was previously employed as an Independent Director by OraSure Technologies, Inc., an Independent Director by FSD Pharma, Inc., a Non-Executive Director by BioAgilytix Labs LLC, an Independent Director by NuPathe, Inc., a Vice Chairman by University City Science Center, an Executive Vice President & Managing Director by Safeguard International Management LLC, an EVP & Managing Director-Life Sciences Group by Safeguard Scientifics, Inc., a Chairman by Clarient, Inc., a Chief Executive Officer by TouchPoint Solutions, a Group President by Dendrite International, Inc., a Group Director-Corporate Business Strategy by GlaxoSmithKline, Inc., a Chief Executive Officer by Golden Land Bhd., a Director-International Business by Baxter Corp., a Member by Ben Franklin Technology Partners /Ventures/, a Chairman by Laureate Biopharmaceutical Services, Inc., a Director-International Business by Merck KGaA, and a Group Director by Smithkline Beckman Corp.
He also served on the board at Acelerate, Inc., Celerant Consulting, Inc., Intralinks Holdings, Inc., NovaSom, Inc., Putney, Inc., Rubicor Medical, Inc., Sotera Wireless, Inc. and Ventaira Pharmaceuticals, Inc. He received his undergraduate degree from Marshall University, an undergraduate degree from The Wharton School of the University of Pennsylvania and an MBA from the University of New Haven.

Postes actifs de Jim Datin

Sociétés	Poste	Début
Hepatitis B Foundation	Directeur/Membre du Conseil	-
Life Sciences Pennsylvania	Directeur/Membre du Conseil	-
The North Carolina Biotechnology Center	Directeur/Membre du Conseil	01/01/2017
BALX Holdings LLC	Directeur Général	-
BioAgilytix Europe GmbH	Directeur Général	-
GHO Capital Partners LLP	Private Equity Investor	01/01/2023

Anciens postes connus de Jim Datin

Sociétés	Poste	Fin
ORASURE TECHNOLOGIES, INC.	Directeur/Membre du Conseil	01/06/2024
BioAgilytix Labs LLC	Directeur Général	16/06/2022
QUANTUM BIOPHARMA LTD.	Directeur/Membre du Conseil	30/04/2021
░░░░░░░░ ░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░